Is the AIDS incubation time changing? A back-calculation approach.

Contradictory literature was recently published on possible changes in AIDS incubation time over the period 1978-1994. The purpose of this work was to test if a change in incubation time (shortening or lengthening) was observed in France, either globally or in specific transmission groups (homosexual-bisexual men, heterosexual subjects), using a back-calculation approach. An age dependent TSI model (time since infection), which took into account a temporary treatment effect and allowed us to test for a change in the incubation time, was applied to the French AIDS cases (Réseau National de Santé Publique). The EM algorithm was used to maximize the likelihood and the best model was selected on the basis of the likelihood ratio statistic. The analysis on all AIDS cases indicated a shortening of the AIDS incubation time estimated to begin in 1983 (95 per cent CI 1982-1984). This shortening of incubation time was also apparent when analysis was restricted to homosexual-bisexual men and to heterosexual subjects. This shortening corresponded to a median incubation time of 9.6 years (95 per cent CI 8.1-10.5) for people infected at 30 years of age in 1983, versus 12.7 years for people infected at 30 years of age before the change.

[1]  I. Marschner,et al.  Using time of first positive HIV test and other auxiliary data in back-projection of AIDS incidence. , 1994, Statistics in medicine.

[2]  Ian C. Marschner,et al.  A method for estimating the age-specific relative risk of HIV infection from AIDS incidence data , 1993 .

[3]  B. Efron,et al.  A Leisurely Look at the Bootstrap, the Jackknife, and , 1983 .

[4]  I. Keet,et al.  Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. , 1996, AIDS.

[5]  P Pezzotti,et al.  Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. , 1992, American journal of epidemiology.

[6]  J. Kaldor,et al.  Development of AIDS in people with transfusion-acquired HIV infection. , 1993, AIDS.

[7]  C. Rouzioux,et al.  Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients , 1994 .

[8]  J. Phair,et al.  The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. , 1994, JAMA.

[9]  P. Ewald.  Evolution of mutation rate and virulence among human retroviruses. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[10]  C. Donnelly,et al.  Demographic approaches to the estimation of incidence of HIV-1 infection among adults from age-specific prevalence data in stable endemic conditions. , 1996, AIDS.

[11]  J. Goedert,et al.  Therapy may explain recent deficits in AIDS incidence. , 1990, Journal of acquired immune deficiency syndromes.

[12]  J. Goedert,et al.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. , 1989, The New England journal of medicine.

[13]  J. Ring,et al.  T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS , 1988, The British journal of dermatology.

[14]  Gerald Myers,et al.  HIV: Between Past and Future , 1994 .

[15]  R. Detels,et al.  Is the Incubation Period of AIDS Lengthening? , 1991, Journal of acquired immune deficiency syndromes.

[16]  James J. Goedert,et al.  Effect of age at seroconversion on the natural AIDS incubation distribution , 1994, AIDS.

[17]  I. Keet,et al.  The role of host genetics in the natural history of HIV‐1 infection: the needles in the haystack , 1996, AIDS.

[18]  Ron Brookmeyer,et al.  MINIMUM SIZE OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) EPIDEMIC IN THE UNITED STATES , 1986, The Lancet.

[19]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[20]  J J Goedert,et al.  Censoring in an epidemic with an application to hemophilia-associated AIDS. , 1989, Biometrics.

[21]  Mitchell H. Gail,et al.  A Method for Obtaining Short-Term Projections and Lower Bounds on the Size of the AIDS Epidemic , 1988 .

[22]  R. Doll,et al.  Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. , 1990, Statistics in medicine.

[23]  D. Cooper,et al.  Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. , 1994, American journal of epidemiology.

[24]  A. Blaxhult,et al.  The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. , 1990, AIDS.

[25]  S W Lagakos,et al.  Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .

[26]  S. Buchbinder,et al.  Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. , 1994, American journal of epidemiology.

[27]  P. Rosenberg.  Backcalculation models of age-specific HIV incidence rates. , 1994, Statistics in medicine.

[28]  M A Nowak,et al.  The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. , 1990, AIDS.

[29]  R. Raiteri,et al.  Is the clinical course of HIV-1 changing? Cohort study , 1997, BMJ.

[30]  H. Schuitemaker,et al.  Virulent HIV strains? , 1993, AIDS.

[31]  R. Carroll,et al.  Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS. , 1992, Statistics in medicine.

[32]  R Brookmeyer,et al.  The analysis of delays in disease reporting: methods and results for the acquired immunodeficiency syndrome. , 1990, American journal of epidemiology.